news Protease inhibitor aprotinin shows promise against SARS-CoV-2 in cells 5 November 2020 | By Victoria Rees (Drug Target Review) Researchers have found that aprotinin, an approved drug for influenza in Russia, combats SARS-CoV-2 in cells.
news Inhibiting growth factor signalling prevents SARS-CoV-2 replication, report researchers 26 August 2020 | By Hannah Balfour (Drug Target Review) Scientists have patented their technique of inhibiting cellular growth factor signalling to stop SARS-CoV-2 replication and treat COVID-19.
news Researchers observe how SARS-CoV-2 changes human cells after infection, revealing drug targets 15 May 2020 | By Victoria Rees (Drug Target Review) Using mass spectrometry, researchers have shown how human cells are changed by infection from SARS-CoV-2, allowing the team to identify drug targets to prevent viral reproduction.